""	"Name"	"Genes (tot)"	"Stat (dist.dir.up)"	"p (dist.dir.up)"	"p adj (dist.dir.up)"	"Stat (dist.dir.dn)"	"p (dist.dir.dn)"	"p adj (dist.dir.dn)"	"Stat (non-dir.)"	"p (non-dir.)"	"p adj (non-dir.)"	"Genes (up)"	"Stat (mix.dir.up)"	"p (mix.dir.up)"	"p adj (mix.dir.up)"	"Genes (down)"	"Stat (mix.dir.dn)"	"p (mix.dir.dn)"	"p adj (mix.dir.dn)"
"1"	"ABC transporters"	11	0.82315	0.39667	1	-0.82315	0.60333	0.81785	-11.71	0.83063	0.99992	8	-11.12	0.91004	0.99826	3	-4.2627	0.48361	0.94831
"2"	"AGE-RAGE signaling pathway in diabetic complications"	39	-0.75497	0.9464	1	0.75497	0.053597	0.19695	-17.351	0.73816	0.99992	17	-11.528	0.76525	0.99826	22	-12.968	0.60478	0.98884
"3"	"AMPK signaling pathway"	56	-0.31135	0.90274	1	0.31135	0.097262	0.28699	-16.979	0.48249	0.97457	25	-9.6941	0.43635	0.96519	31	-14.115	0.49124	0.94831
"4"	"Acute myeloid leukemia"	28	-0.14292	0.82267	1	0.14292	0.17733	0.40975	-17.181	0.89273	0.99992	12	-7.7071	0.53563	0.99826	16	-16.054	0.93711	0.99965
"5"	"Adherens junction"	32	-0.69496	0.90654	1	0.69496	0.093457	0.28222	-10.451	0.25631	0.74453	13	-2.0538	0.092354	0.65527	19	-11.864	0.5683	0.97431
"6"	"Adipocytokine signaling pathway"	31	0.62672	0.60611	1	-0.62672	0.39389	0.64245	-18.366	0.90771	0.99992	10	-6.7831	0.50294	0.97958	21	-17.633	0.93312	0.99965
"7"	"Adrenergic signaling in cardiomyocytes"	57	-3.2772	0.99992	1	3.2772	7.5413e-05	0.0023001	-11.462	0.06759	0.43011	19	-5.957	0.22537	0.85015	38	-9.8254	0.06364	0.63733
"8"	"African trypanosomiasis"	14	0.060311	0.69424	1	-0.060311	0.30576	0.55202	-6.8836	0.33027	0.84649	7	-7.2613	0.64875	0.99826	7	-2.4736	0.13944	0.80097
"9"	"Alanine, aspartate and glutamate metabolism"	16	4.5847	0.00026313	0.0034893	-4.5847	0.99974	1	-1.7173	0.028907	0.28441	14	-2.2551	0.097674	0.65833	2	1.1094	0.11312	0.79773
"10"	"Alcoholism"	29	0.66462	0.54012	1	-0.66462	0.45988	0.69829	-9.5579	0.24409	0.73863	13	-1.0743	0.059395	0.50233	16	-11.899	0.67654	0.99965
"11"	"Aldosterone synthesis and secretion"	24	-2.3047	0.99504	1	2.3047	0.0049626	0.044305	-9.24	0.30941	0.82714	8	-9.256	0.81158	0.99826	16	-4.7716	0.083399	0.7394
"12"	"Aldosterone-regulated sodium reabsorption"	16	-0.028694	0.73747	1	0.028694	0.26253	0.5036	-10.465	0.6008	0.99992	5	0.033785	0.12461	0.72319	11	-12.644	0.86537	0.99965
"13"	"Allograft rejection"	4	-0.12261	0.64939	1	0.12261	0.35061	0.60077	-9.1307	0.87237	0.99992	3	-10.221	0.93889	0.99826	1	-0.55719	0.31666	0.85849
"14"	"Alzheimer disease"	113	18.276	0	0	-18.276	1	1	10.506	0	0	92	13.755	2.2204e-16	1.3234e-14	21	-4.4201	0.032135	0.5887
"15"	"Amino sugar and nucleotide sugar metabolism"	27	1.1942	0.40133	1	-1.1942	0.59867	0.81515	-6.0919	0.064127	0.43011	16	-3.641	0.12619	0.72319	11	-5.153	0.22006	0.83439
"16"	"Aminoacyl-tRNA biosynthesis"	21	6.4017	3.0293e-07	6.1597e-06	-6.4017	1	1	-2.3357	0.020092	0.22697	20	-2.1768	0.038239	0.44763	1	-0.9687	0.35418	0.89746
"17"	"Amoebiasis"	42	0.19424	0.75817	1	-0.19424	0.24183	0.48524	-14.886	0.49097	0.97872	21	-9.2074	0.46647	0.96757	21	-11.845	0.51277	0.9542
"18"	"Amphetamine addiction"	20	-3.7787	0.99993	1	3.7787	6.6727e-05	0.0022613	-2.6642	0.029872	0.28472	3	0.34656	0.1785	0.78225	17	-3.0354	0.032593	0.5887
"19"	"Amyotrophic lateral sclerosis (ALS)"	21	-0.57299	0.87164	1	0.57299	0.12836	0.3559	-4.4901	0.064077	0.43011	12	-5.4117	0.32325	0.9174	9	-0.60983	0.045163	0.61297
"20"	"Antigen processing and presentation"	24	0.55459	0.56632	1	-0.55459	0.43368	0.67831	-9.0947	0.29683	0.8198	17	-10.545	0.68627	0.99826	7	-0.40745	0.055146	0.61297
"21"	"Apelin signaling pathway"	54	1.3022	0.45574	1	-1.3022	0.54426	0.75106	-17.135	0.5101	0.9847	25	-6.3873	0.1773	0.78225	29	-17.451	0.8209	0.99965
"22"	"Apoptosis"	49	0.4996	0.72669	1	-0.4996	0.27331	0.51775	-19.19	0.77267	0.99992	21	-10.477	0.58922	0.99826	28	-16.313	0.74843	0.99965
"23"	"Arachidonic acid metabolism"	15	0.95394	0.3882	1	-0.95394	0.6118	0.82184	-8.4027	0.42624	0.91644	7	-4.7571	0.40861	0.96519	8	-7.056	0.48759	0.94831
"24"	"Arginine and proline metabolism"	27	4.8155	0.00059395	0.0067507	-4.8155	0.99941	1	-1.7672	0.0045234	0.07207	19	-0.30297	0.016152	0.24868	8	-2.7796	0.13675	0.80097
"25"	"Arginine biosynthesis"	11	4.6318	0.00014962	0.0020743	-4.6318	0.99985	1	-1.5841	0.073018	0.43667	11	-1.5841	0.10162	0.65833	0			
"26"	"Arrhythmogenic right ventricular cardiomyopathy (ARVC)"	36	-1.8106	0.99086	1	1.8106	0.0091362	0.067964	-11.694	0.29835	0.8198	13	-7.0111	0.44246	0.96519	23	-9.3596	0.2252	0.83439
"27"	"Ascorbate and aldarate metabolism"	6	1.6907	0.12862	0.7692	-1.6907	0.87138	1	-1.1927	0.13209	0.64677	4	-1.7152	0.28159	0.88798	2	0.35981	0.15496	0.80097
"28"	"Asthma"	2	0.088304	0.53412	1	-0.088304	0.46588	0.69996	-6.7137	0.80326	0.99992	2	-6.7137	0.82644	0.99826	0			
"29"	"Autoimmune thyroid disease"	4	-0.12261	0.64939	1	0.12261	0.35061	0.60077	-9.1307	0.87237	0.99992	3	-10.221	0.93889	0.99826	1	-0.55719	0.31666	0.85849
"30"	"Autophagy"	56	0.74457	0.66037	1	-0.74457	0.33963	0.59532	-23.652	0.94208	0.99992	26	-9.7633	0.395	0.96519	30	-23.225	0.98957	0.99965
"31"	"Axon guidance"	55	-1.3997	0.98761	1	1.3997	0.012387	0.082132	-18.526	0.63896	0.99992	24	-13.984	0.81696	0.99826	31	-12.371	0.32199	0.85849
"32"	"B cell receptor signaling pathway"	27	-2.0117	0.99177	1	2.0117	0.0082254	0.062719	-16.195	0.847	0.99992	8	-9.1139	0.80203	0.99826	19	-13.392	0.71337	0.99965
"33"	"Bacterial invasion of epithelial cells"	42	1.1316	0.46374	1	-1.1316	0.53626	0.75106	-13.667	0.37324	0.9053	23	-7.8598	0.31171	0.91069	19	-11.672	0.54885	0.96187
"34"	"Basal cell carcinoma"	4	-0.057577	0.62882	1	0.057577	0.37118	0.61863	-12.98	0.98279	0.99992	2	-11.61	0.98384	0.99826	2	-6.7458	0.7968	0.99965
"35"	"Basal transcription factors"	4	-0.32233	0.70964	1	0.32233	0.29036	0.53672	-8.4219	0.83089	0.99992	1	-0.78721	0.37403	0.96519	3	-9.2703	0.89156	0.99965
"36"	"Base excision repair"	8	0.081485	0.63558	1	-0.081485	0.36442	0.61358	-15.766	0.98639	0.99992	4	-12.526	0.97689	0.99826	4	-9.77	0.89179	0.99965
"37"	"Bile secretion"	15	0.40641	0.56937	1	-0.40641	0.43063	0.67702	-9.1588	0.49963	0.98009	6	-5.8806	0.56797	0.99826	9	-7.0225	0.45156	0.94677
"38"	"Biosynthesis of unsaturated fatty acids"	11	2.171	0.073682	0.53507	-2.171	0.92632	1	-6.4325	0.38227	0.9053	7	-3.6925	0.31146	0.91069	4	-5.7824	0.58324	0.97431
"39"	"Bladder cancer"	12	-0.015004	0.68762	1	0.015004	0.31238	0.55393	-9.6301	0.66	0.99992	5	-6.9104	0.68443	0.99826	7	-6.7684	0.49428	0.94831
"40"	"Breast cancer"	22	-0.99105	0.92943	1	0.99105	0.070572	0.23396	-16.897	0.93803	0.99992	8	-11.411	0.92108	0.99826	14	-12.555	0.76252	0.99965
"41"	"Butanoate metabolism"	16	7.1745	3.9613e-09	9.2937e-08	-7.1745	1	1	-1.9033	0.032062	0.28761	15	0.15398	0.023294	0.31553	1	-8.2095	0.92488	0.99965
"42"	"C-type lectin receptor signaling pathway"	33	-1.8396	0.9925	1	1.8396	0.0074953	0.058617	-16.403	0.75954	0.99992	8	-6.129	0.54648	0.99826	25	-15.379	0.748	0.99965
"43"	"Calcium signaling pathway"	51	-2.5298	0.9993	1	2.5298	0.00069626	0.011201	-6.4126	0.0047259	0.07207	21	-4.8555	0.12591	0.72319	30	-4.2986	0.0084058	0.33513
"44"	"Carbohydrate digestion and absorption"	12	-1.099	0.92197	1	1.099	0.07803	0.25052	-7.2138	0.4255	0.91644	4	-1.23	0.24399	0.88478	8	-7.9653	0.57736	0.97431
"45"	"Cardiac muscle contraction"	41	7.552	1.4873e-08	3.2403e-07	-7.552	1	1	2.9909	1.1923e-05	0.00036366	30	6.375	6.1717e-06	0.00018392	11	-4.7537	0.1916	0.82756
"46"	"Cell adhesion molecules (CAMs)"	24	1.4318	0.28341	1	-1.4318	0.71659	0.91067	-21.74	0.99534	0.99992	18	-18.686	0.99053	0.99826	6	-11.114	0.8967	0.99965
"47"	"Cell cycle"	32	-2.2987	0.9963	1	2.2987	0.0036999	0.037616	-24.146	0.99784	0.99992	5	-14.353	0.98712	0.99826	27	-20.111	0.95571	0.99965
"48"	"Cellular senescence"	49	-0.66701	0.94922	1	0.66701	0.050785	0.1931	-12.07	0.15827	0.64909	19	-5.7802	0.21258	0.83969	30	-10.826	0.22081	0.83439
"49"	"Central carbon metabolism in cancer"	33	1.1554	0.41928	1	-1.1554	0.58072	0.79426	-9.033	0.14779	0.64677	18	-5.5001	0.20007	0.83969	15	-7.3731	0.2905	0.85849
"50"	"Chagas disease (American trypanosomiasis)"	33	-0.29157	0.85768	1	0.29157	0.14232	0.36785	-20.494	0.95318	0.99992	13	-10.867	0.78067	0.99826	20	-17.563	0.94221	0.99965
"51"	"Chemical carcinogenesis"	21	2.9787	0.023621	0.20013	-2.9787	0.97638	1	-4.6128	0.067953	0.43011	17	-1.2597	0.039055	0.44763	4	-7.9721	0.7804	0.99965
"52"	"Chemokine signaling pathway"	50	0.14149	0.8092	1	-0.14149	0.1908	0.4279	-23.746	0.96468	0.99992	22	-9.6652	0.48308	0.97958	28	-23.165	0.99264	0.99965
"53"	"Cholesterol metabolism"	21	1.51	0.24364	1	-1.51	0.75636	0.94296	-6.2055	0.13587	0.64677	16	-6.6636	0.3311	0.92212	5	-0.79712	0.11317	0.79773
"54"	"Choline metabolism in cancer"	35	-0.60022	0.9012	1	0.60022	0.098801	0.28699	-15.941	0.70907	0.99992	17	-10.276	0.66283	0.99826	18	-12.243	0.67005	0.99965
"55"	"Cholinergic synapse"	30	-1.2107	0.96774	1	1.2107	0.032262	0.155	-12.076	0.45964	0.94087	11	-4.7211	0.30087	0.90566	19	-11.582	0.5397	0.96187
"56"	"Chronic myeloid leukemia"	30	-1.4331	0.97959	1	1.4331	0.02041	0.11116	-19.267	0.9494	0.99992	12	-13.005	0.91221	0.99826	18	-14.255	0.82988	0.99965
"57"	"Circadian entrainment"	29	-1.3864	0.96748	1	1.3864	0.032524	0.155	-8.9521	0.20024	0.70507	11	-4.4275	0.27688	0.88798	18	-7.9017	0.2521	0.85714
"58"	"Circadian rhythm"	9	-1.5479	0.94701	1	1.5479	0.052986	0.19695	-6.285	0.4515	0.93763	1	-8.2095	0.92946	0.99826	8	-3.7637	0.19761	0.82756
"59"	"Citrate cycle (TCA cycle)"	29	13.602	0	0	-13.602	1	1	8.9626	9.7454e-08	3.3026e-06	28	10.673	8.0937e-08	3.0149e-06	1	-8.2095	0.92488	0.99965
"60"	"Cocaine addiction"	10	1.1517	0.28824	1	-1.1517	0.71176	0.90831	-5.589	0.33568	0.85319	5	0.24187	0.11484	0.72319	5	-8.1459	0.73673	0.99965
"61"	"Collecting duct acid secretion"	11	1.4174	0.21613	1	-1.4174	0.78387	0.96346	-3.3647	0.15155	0.64909	8	-2.9462	0.25338	0.88478	3	-1.6318	0.2384	0.85714
"62"	"Colorectal cancer"	31	0.061431	0.77765	1	-0.061431	0.22235	0.46756	-16.377	0.79964	0.99992	11	-3.5984	0.21463	0.83969	20	-17.72	0.94674	0.99965
"63"	"Complement and coagulation cascades"	38	1.2061	0.45787	1	-1.2061	0.54213	0.75106	-16.978	0.74251	0.99992	28	-14.615	0.7896	0.99826	10	-8.6414	0.56828	0.97431
"64"	"Cortisol synthesis and secretion"	9	-0.42647	0.75494	1	0.42647	0.24506	0.48851	-5.7532	0.4002	0.91365	4	-4.3465	0.51905	0.99825	5	-3.8312	0.32676	0.85849
"65"	"Cushing syndrome"	33	-1.1051	0.96295	1	1.1051	0.037045	0.16588	-14.297	0.58102	0.99992	13	-10.402	0.74647	0.99826	20	-9.9791	0.35029	0.89695
"66"	"Cysteine and methionine metabolism"	29	3.6751	0.0069607	0.066345	-3.6751	0.99304	1	-0.44044	0.0017848	0.030243	18	2.713	0.0023481	0.053826	11	-4.1856	0.1552	0.80097
"67"	"Cytokine-cytokine receptor interaction"	3	-0.34061	0.71316	1	0.34061	0.28684	0.53672	-9.5597	0.91945	0.99992	0				3	-9.5597	0.90466	0.99965
"68"	"Cytosolic DNA-sensing pathway"	11	0.1287	0.63667	1	-0.1287	0.36333	0.61358	-19.628	0.99776	0.99992	4	-11.772	0.96516	0.99826	7	-15.706	0.98642	0.99965
"69"	"D-Glutamine and D-glutamate metabolism"	3	1.172	0.24254	1	-1.172	0.75746	0.94296	-4.739	0.58012	0.99992	3	-4.739	0.60485	0.99826	0			
"70"	"DNA replication"	9	-0.7402	0.82877	1	0.7402	0.17123	0.40173	-9.5871	0.75537	0.99992	2	-4.2562	0.63224	0.99826	7	-8.5958	0.67014	0.99965
"71"	"Dilated cardiomyopathy (DCM)"	45	-1.0977	0.96696	1	1.0977	0.033043	0.15505	-9.7639	0.086421	0.48812	18	-4.6794	0.14921	0.7667	27	-8.7845	0.13248	0.80097
"72"	"Dopaminergic synapse"	46	-2.3428	0.99814	1	2.3428	0.0018644	0.023694	-12.184	0.20835	0.71401	13	-3.0296	0.13702	0.74242	33	-12.484	0.27603	0.85849
"73"	"Drug metabolism"	38	2.7993	0.067491	0.50207	-2.7993	0.93251	1	-12.455	0.32351	0.8362	30	-10.473	0.3707	0.96519	8	-6.863	0.46847	0.94677
"74"	"ECM-receptor interaction"	38	2.5952	0.093941	0.58474	-2.5952	0.90606	1	-13.787	0.44779	0.93763	26	-9.4776	0.36862	0.96519	12	-10.583	0.67771	0.99965
"75"	"Endocrine and other factor-regulated calcium reabsorption"	21	-0.93353	0.92657	1	0.93353	0.073429	0.24081	-12.612	0.68375	0.99992	7	-10.718	0.89031	0.99826	14	-7.8671	0.31728	0.85849
"76"	"Endocytosis"	125	-0.32118	0.96247	1	0.32118	0.037528	0.16588	-24.727	0.37813	0.9053	58	-15.703	0.48325	0.97958	67	-19.163	0.3134	0.85849
"77"	"Endometrial cancer"	20	-0.48275	0.83781	1	0.48275	0.16219	0.38952	-12.837	0.71549	0.99992	8	-6.0394	0.53776	0.99826	12	-11.641	0.76756	0.99965
"78"	"Epithelial cell signaling in Helicobacter pylori infection"	30	0.73575	0.55024	1	-0.73575	0.44976	0.69632	-17.29	0.87711	0.99992	18	-12.391	0.79524	0.99826	12	-12.163	0.8061	0.99965
"79"	"Epstein-Barr virus infection"	74	-2.8984	0.99988	1	2.8984	0.00011911	0.0032084	-29.256	0.98927	0.99992	28	-22.863	0.99725	0.99826	46	-19.269	0.6766	0.99965
"80"	"ErbB signaling pathway"	39	-2.2228	0.99817	1	2.2228	0.0018263	0.023694	-18.2	0.80007	0.99992	15	-12.619	0.87656	0.99826	24	-13.223	0.57644	0.97431
"81"	"Estrogen signaling pathway"	34	-0.26196	0.85136	1	0.26196	0.14864	0.37467	-10.481	0.25349	0.74342	15	-5.6509	0.28794	0.88798	19	-8.999	0.28713	0.85849
"82"	"Ether lipid metabolism"	10	-0.84953	0.87757	1	0.84953	0.12243	0.34259	-13.782	0.94195	0.99992	4	-16.419	0.99825	0.99826	6	-4.3862	0.32072	0.85849
"83"	"Fanconi anemia pathway"	5	-2.0554	0.98049	1	2.0554	0.019511	0.1082	-5.8046	0.54296	0.99992	0				5	-5.8046	0.51837	0.9542
"84"	"Fat digestion and absorption"	9	1.5717	0.16836	0.96837	-1.5717	0.83164	1	-4.7932	0.31231	0.82714	7	-5.1792	0.44917	0.96519	2	-0.47859	0.21254	0.83007
"85"	"Fatty acid biosynthesis"	7	1.5297	0.17579	0.96837	-1.5297	0.82421	1	-2.0933	0.16781	0.6647	3	2.3945	0.080891	0.63435	4	-4.8429	0.48742	0.94831
"86"	"Fatty acid degradation"	32	8.6363	2.2792e-11	5.7929e-10	-8.6363	1	1	-0.9354	0.00099321	0.017819	28	0.3844	0.0027209	0.057916	4	-3.6627	0.36876	0.91086
"87"	"Fatty acid elongation"	15	5.7038	1.0037e-05	0.00015306	-5.7038	0.99999	1	0.16228	0.011245	0.1429	11	3.6764	0.0056898	0.10597	4	-5.7824	0.58324	0.97431
"88"	"Fc epsilon RI signaling pathway"	27	-1.2285	0.96009	1	1.2285	0.039915	0.17147	-14.583	0.73156	0.99992	10	-6.9489	0.51923	0.99825	17	-13.048	0.73548	0.99965
"89"	"Fc gamma R-mediated phagocytosis"	41	-0.86587	0.94162	1	0.86587	0.058383	0.20467	-11.965	0.24944	0.73863	19	-7.7153	0.37335	0.96519	22	-9.164	0.24661	0.85714
"90"	"Ferroptosis"	21	0.6984	0.50716	1	-0.6984	0.49284	0.72531	-6.3734	0.14509	0.64677	10	-2.8884	0.17051	0.78225	11	-6.0522	0.29229	0.85849
"91"	"Fluid shear stress and atherosclerosis"	58	0.89431	0.61032	1	-0.89431	0.38968	0.64059	-21.794	0.85934	0.99992	28	-10.862	0.46341	0.96757	30	-19.809	0.92814	0.99965
"92"	"Focal adhesion"	101	0.29063	0.86532	1	-0.29063	0.13468	0.36034	-19.92	0.20326	0.70507	54	-12.213	0.21978	0.83969	47	-16.11	0.37598	0.91964
"93"	"Folate biosynthesis"	11	0.90108	0.37047	1	-0.90108	0.62953	0.83481	-1.4629	0.069099	0.43011	6	-1.9691	0.21503	0.83969	5	-0.012716	0.079779	0.7394
"94"	"FoxO signaling pathway"	42	-1.6243	0.98732	1	1.6243	0.012677	0.082265	-17.477	0.73105	0.99992	12	-12.608	0.89611	0.99826	30	-12.705	0.38105	0.91964
"95"	"Fructose and mannose metabolism"	21	-1.3551	0.96568	1	1.3551	0.034317	0.15859	-3.9353	0.048658	0.38053	11	-7.5697	0.56339	0.99826	10	2.2364	0.006559	0.33513
"96"	"GABAergic synapse"	19	-0.1926	0.78713	1	0.1926	0.21287	0.45088	-8.7829	0.37688	0.9053	9	-5.2106	0.3902	0.96519	10	-7.1631	0.42524	0.94189
"97"	"Galactose metabolism"	15	-0.96489	0.90722	1	0.96489	0.09278	0.28222	-3.7438	0.092403	0.51242	9	-3.8937	0.2766	0.88798	6	-1.1506	0.097303	0.78638
"98"	"Gap junction"	28	-1.0778	0.95712	1	1.0778	0.042881	0.17916	-10.619	0.3596	0.89745	11	-9.5809	0.73914	0.99826	17	-5.9219	0.12904	0.80097
"99"	"Gastric acid secretion"	23	-1.7557	0.9818	1	1.7557	0.018196	0.10471	-4.8722	0.056451	0.40041	7	-3.079	0.26047	0.88478	16	-3.805	0.051321	0.61297
"100"	"Gastric cancer"	29	-1.1485	0.94976	1	1.1485	0.050239	0.1931	-20.624	0.97736	0.99992	10	-10.53	0.8239	0.99826	19	-17.841	0.95568	0.99965
"101"	"Glioma"	25	-2.4622	0.99752	1	2.4622	0.0024832	0.028051	-12.916	0.62026	0.99992	9	-13.495	0.9552	0.99826	16	-6.0232	0.14472	0.80097
"102"	"Glucagon signaling pathway"	49	-1.775	0.9956	1	1.775	0.0043999	0.041937	-11.86	0.14614	0.64677	17	-9.4614	0.58829	0.99826	32	-7.7803	0.046748	0.61297
"103"	"Glutamatergic synapse"	27	-1.0306	0.94388	1	1.0306	0.056122	0.20138	-8.775	0.19899	0.70507	9	-4.9245	0.36427	0.96519	18	-7.265	0.20316	0.82756
"104"	"Glutathione metabolism"	34	3.5155	0.012513	0.11225	-3.5155	0.98749	1	-6.4649	0.052058	0.39694	25	-3.4584	0.054388	0.50233	9	-6.8017	0.43021	0.94189
"105"	"Glycerolipid metabolism"	20	1.1415	0.34042	1	-1.1415	0.65958	0.85971	-6.2776	0.15585	0.64909	12	-5.7786	0.35531	0.96519	8	-2.8484	0.14054	0.80097
"106"	"Glycerophospholipid metabolism"	29	0.088956	0.7225	1	-0.088956	0.2775	0.52246	-17.633	0.89859	0.99992	16	-15.815	0.95597	0.99826	13	-8.7908	0.45242	0.94677
"107"	"Glycine, serine and threonine metabolism"	17	3.1483	0.016214	0.14129	-3.1483	0.98379	1	-3.849	0.072416	0.43667	13	-4.1795	0.20619	0.83969	4	-0.4002	0.12009	0.80097
"108"	"Glycolysis / Gluconeogenesis"	47	0.22412	0.74835	1	-0.22412	0.25165	0.49202	0.99718	1.9462e-05	0.00049465	25	-0.84876	0.013629	0.22564	22	2.3623	0.00018106	0.026163
"109"	"Glycosaminoglycan degradation"	5	2.2422	0.061965	0.47248	-2.2422	0.93804	1	-5.8083	0.54333	0.99992	5	-5.8083	0.58748	0.99826	0			
"110"	"Glycosphingolipid biosynthesis"	2	1.8966	0.077892	0.55249	-1.8966	0.92211	1	0.97014	0.14808	0.64677	2	0.97014	0.17276	0.78225	0			
"111"	"Glycosylphosphatidylinositol (GPI)-anchor biosynthesis"	4	0.40211	0.47627	1	-0.40211	0.52373	0.74297	-9.1133	0.87145	0.99992	1	0.23631	0.28487	0.88798	3	-10.66	0.94395	0.99965
"112"	"Glyoxylate and dicarboxylate metabolism"	23	8.9654	4.0994e-12	1.1366e-10	-8.9654	1	1	3.5372	0.00010957	0.0023871	22	3.6645	0.00050253	0.012479	1	-0.22387	0.28757	0.85849
"113"	"GnRH signaling pathway"	33	-3.2103	0.99986	1	3.2103	0.00013675	0.0032084	-10.433	0.23779	0.73863	9	-7.0489	0.56345	0.99826	24	-7.9171	0.13585	0.80097
"114"	"Graft-versus-host disease"	4	-0.12261	0.64939	1	0.12261	0.35061	0.60077	-9.1307	0.87237	0.99992	3	-10.221	0.93889	0.99826	1	-0.55719	0.31666	0.85849
"115"	"HIF-1 signaling pathway"	51	-2.3196	0.99872	1	2.3196	0.0012807	0.017756	-13.227	0.19349	0.70254	19	-9.5172	0.54731	0.99826	32	-9.3646	0.10068	0.78638
"116"	"Hedgehog signaling pathway"	9	-2.309	0.98763	1	2.309	0.012372	0.082132	-9.5239	0.75045	0.99992	0				9	-9.5239	0.68845	0.99965
"117"	"Hematopoietic cell lineage"	14	1.4511	0.25506	1	-1.4511	0.74494	0.93887	-11.694	0.76321	0.99992	10	-5.526	0.3812	0.96519	4	-13.14	0.98227	0.99965
"118"	"Hepatitis B"	53	-1.1723	0.98105	1	1.1723	0.018951	0.10704	-23.844	0.95413	0.99992	18	-14.159	0.89475	0.99826	35	-19.188	0.83547	0.99965
"119"	"Hepatitis C"	50	-1.4043	0.98403	1	1.4043	0.01597	0.095506	-22.179	0.92161	0.99992	15	-13.663	0.92149	0.99826	35	-17.564	0.71339	0.99965
"120"	"Hepatocellular carcinoma"	43	-1.1369	0.96925	1	1.1369	0.030749	0.15375	-18.19	0.77628	0.99992	18	-11.81	0.75313	0.99826	25	-13.835	0.60562	0.98884
"121"	"Herpes simplex virus 1 infection"	59	0.062046	0.84753	1	-0.062046	0.15247	0.37807	-26.669	0.98777	0.99992	27	-17.215	0.93362	0.99826	32	-20.4	0.93389	0.99965
"122"	"Hippo signaling pathway"	34	-3.1036	0.99978	1	3.1036	0.00022217	0.0045175	-17.208	0.82832	0.99992	8	-14.805	0.98761	0.99826	26	-11.466	0.32263	0.85849
"123"	"Histidine metabolism"	10	2.0993	0.084783	0.57987	-2.0993	0.91522	1	2.3722	0.0090521	0.12004	7	2.1965	0.026595	0.34458	3	0.97589	0.08443	0.7394
"124"	"Homologous recombination"	8	-1.1308	0.91467	1	1.1308	0.085327	0.2683	-4.5464	0.30843	0.82714	2	-0.30677	0.26425	0.88478	6	-5.0726	0.38617	0.92234
"125"	"Human T-cell leukemia virus 1 infection"	61	1.0369	0.57357	1	-1.0369	0.42643	0.67702	-23.155	0.88793	0.99992	31	-12.018	0.53975	0.99826	30	-20.801	0.95622	0.99965
"126"	"Human cytomegalovirus infection"	77	-0.33296	0.93344	1	0.33296	0.066564	0.22558	-28.197	0.97564	0.99992	36	-20.53	0.97156	0.99826	41	-19.404	0.78433	0.99965
"127"	"Human immunodeficiency virus 1 infection"	80	-1.2328	0.98836	1	1.2328	0.011642	0.0807	-25.938	0.89978	0.99992	29	-14.262	0.76549	0.99826	51	-21.731	0.8118	0.99965
"128"	"Human papillomavirus infection"	110	0.50208	0.85183	1	-0.50208	0.14817	0.37467	-35.829	0.99719	0.99992	53	-23.451	0.97717	0.99826	57	-27.16	0.97875	0.99965
"129"	"Huntington disease"	113	21.302	0	0	-21.302	1	1	6.3552	2.6201e-14	1.5983e-12	97	13.934	0	0	16	-17.419	0.97017	0.99965
"130"	"Hypertrophic cardiomyopathy (HCM)"	48	-0.63688	0.94085	1	0.63688	0.059151	0.20501	-12.571	0.21327	0.71482	20	-8.1106	0.37267	0.96519	28	-9.6049	0.14396	0.80097
"131"	"IL-17 signaling pathway"	25	-0.10417	0.79087	1	0.10417	0.20913	0.44984	-20.604	0.98723	0.99992	10	-9.0606	0.71513	0.99826	15	-19.201	0.98845	0.99965
"132"	"Inflammatory bowel disease (IBD)"	8	-0.65616	0.83383	1	0.65616	0.16617	0.39595	-9.6042	0.76448	0.99992	2	-6.7137	0.82644	0.99826	6	-7.2139	0.60291	0.98884
"133"	"Inflammatory mediator regulation of TRP channels"	29	-3.2221	0.99967	1	3.2221	0.00032968	0.0062846	-11.551	0.41771	0.91644	7	-10.624	0.88594	0.99826	22	-7.269	0.12326	0.80097
"134"	"Influenza A"	56	-0.16706	0.88031	1	0.16706	0.11969	0.33801	-17.709	0.55286	0.99992	23	-9.3603	0.44913	0.96519	33	-15.254	0.54916	0.96187
"135"	"Inositol phosphate metabolism"	24	-0.90515	0.91896	1	0.90515	0.08104	0.25747	-14.542	0.79282	0.99992	11	-12.417	0.90646	0.99826	13	-8.3365	0.4065	0.934
"136"	"Insulin resistance"	53	-0.9847	0.97214	1	0.9847	0.027865	0.14653	-22.128	0.89809	0.99992	18	-10.424	0.63654	0.99826	35	-19.754	0.86858	0.99965
"137"	"Insulin secretion"	22	-3.102	0.99953	1	3.102	0.00047259	0.0084788	-9.7189	0.39332	0.91365	4	-8.9918	0.87549	0.99826	18	-6.5059	0.15288	0.80097
"138"	"Insulin signaling pathway"	77	-1.5103	0.99424	1	1.5103	0.0057591	0.048138	-26.019	0.92519	0.99992	33	-17.382	0.90506	0.99826	44	-19.367	0.72456	0.99965
"139"	"Intestinal immune network for IgA production"	2	0.088304	0.53412	1	-0.088304	0.46588	0.69996	-6.7137	0.80326	0.99992	2	-6.7137	0.82644	0.99826	0			
"140"	"JAK-STAT signaling pathway"	18	-1.5031	0.96829	1	1.5031	0.031715	0.155	-15.15	0.89645	0.99992	6	-8.0314	0.75781	0.99826	12	-12.876	0.85205	0.99965
"141"	"Kaposi sarcoma-associated herpesvirus infection"	59	-0.47885	0.93153	1	0.47885	0.06847	0.22949	-24.604	0.95873	0.99992	23	-15.34	0.90646	0.99826	36	-19.237	0.85227	0.99965
"142"	"Legionellosis"	23	-0.43853	0.84031	1	0.43853	0.15969	0.38655	-3.7589	0.031111	0.28754	8	1.3055	0.043937	0.45242	15	-5.608	0.1652	0.82271
"143"	"Leishmaniasis"	15	0.022396	0.69025	1	-0.022396	0.30975	0.55248	-13.163	0.83622	0.99992	6	-9.6943	0.86597	0.99826	9	-9.0782	0.64885	0.99965
"144"	"Leukocyte transendothelial migration"	50	-0.10754	0.85984	1	0.10754	0.14016	0.36785	-16.059	0.45498	0.93763	30	-14.516	0.73879	0.99826	20	-7.6141	0.15984	0.81039
"145"	"Linoleic acid metabolism"	3	-0.28009	0.69574	1	0.28009	0.30426	0.55202	-9.6675	0.92338	0.99992	1	-8.2095	0.92946	0.99826	2	-6.0351	0.74075	0.99965
"146"	"Long-term depression"	24	-0.78078	0.90203	1	0.78078	0.097967	0.28699	-8.2854	0.23146	0.73778	9	-5.1397	0.38372	0.96519	15	-6.4991	0.22345	0.83439
"147"	"Long-term potentiation"	29	-3.9434	0.99997	1	3.9434	2.9188e-05	0.0012718	-5.8355	0.054816	0.39807	6	-4.477	0.43118	0.96519	23	-4.2659	0.019571	0.43508
"148"	"Longevity regulating pathway"	44	0.34791	0.73538	1	-0.34791	0.26462	0.50443	-22.716	0.96615	0.99992	21	-12.604	0.77176	0.99826	23	-19.376	0.9654	0.99965
"149"	"Lysine degradation"	22	5.2218	4.2718e-05	0.00062043	-5.2218	0.99996	1	-1.2038	0.0078259	0.10849	17	-1.8463	0.052637	0.50233	5	0.87923	0.051523	0.61297
"150"	"Lysosome"	41	2.5988	0.087154	0.57987	-2.5988	0.91285	1	-21.441	0.94208	0.99992	28	-11.842	0.55663	0.99826	13	-20.697	0.99839	0.99965
"151"	"MAPK signaling pathway"	80	-3.3606	0.99998	1	3.3606	2.1582e-05	0.0010971	-22.818	0.69673	0.99992	26	-12.143	0.62179	0.99826	54	-19.347	0.54424	0.96187
"152"	"Malaria"	13	0.25412	0.63386	1	-0.25412	0.36614	0.61358	-10.373	0.68342	0.99992	6	-9.8549	0.8743	0.99826	7	-5.0123	0.32591	0.85849
"153"	"Mannose type O-glycan biosynthesis"	1	0	0.53982	1	0	0.46018	0.69829	-8.2095	0.9293	0.99992	0				1	-8.2095	0.92488	0.99965
"154"	"Maturity onset diabetes of the young"	1	0	0.53982	1	0	0.46018	0.69829	-8.2095	0.9293	0.99992	1	-8.2095	0.92946	0.99826	0			
"155"	"Measles"	40	-0.85001	0.95017	1	0.85001	0.049829	0.1931	-21.691	0.95699	0.99992	16	-14.623	0.92316	0.99826	24	-16.063	0.81168	0.99965
"156"	"Melanogenesis"	23	-1.882	0.98602	1	1.882	0.013984	0.085503	-9.2646	0.31458	0.82714	6	-6.0531	0.58456	0.99826	17	-7.1801	0.20608	0.82756
"157"	"Melanoma"	14	-0.29167	0.78905	1	0.29167	0.21095	0.44992	-13.403	0.87019	0.99992	5	-7.4812	0.7305	0.99826	9	-11.14	0.81264	0.99965
"158"	"Metabolism of xenobiotics by cytochrome P450"	19	2.6005	0.051076	0.40995	-2.6005	0.94892	1	-5.095	0.11614	0.61074	16	-3.6184	0.1251	0.72319	3	-4.4657	0.50424	0.94831
"159"	"MicroRNAs in cancer"	43	-0.86281	0.94933	1	0.86281	0.050665	0.1931	-24.921	0.99194	0.99992	20	-20.495	0.99648	0.99826	23	-14.964	0.75309	0.99965
"160"	"Mineral absorption"	12	-0.33024	0.77619	1	0.33024	0.22381	0.46756	-5.7637	0.2918	0.8165	6	-4.6683	0.44971	0.96519	6	-3.4827	0.24264	0.85714
"161"	"Mismatch repair"	7	-0.81077	0.8486	1	0.81077	0.1514	0.37807	-7.1808	0.61375	0.99992	2	-4.2562	0.63224	0.99826	5	-5.8046	0.51837	0.9542
"162"	"Mitophagy"	33	0.95924	0.4876	1	-0.95924	0.5124	0.73334	-15.961	0.72562	0.99992	17	-8.5433	0.50037	0.97958	16	-14.115	0.84856	0.99965
"163"	"Morphine addiction"	14	0.7922	0.45779	1	-0.7922	0.54221	0.75106	-8.7607	0.50473	0.98053	5	0.80299	0.091252	0.65527	9	-11.525	0.83695	0.99965
"164"	"Mucin type O-glycan biosynthesis"	1	0.047087	0.52435	1	-0.047087	0.47565	0.70955	-1.7798	0.45316	0.93763	1	-1.7798	0.46755	0.96757	0			
"165"	"N-Glycan biosynthesis"	13	-0.88794	0.90818	1	0.88794	0.091818	0.28222	-12.057	0.81458	0.99992	6	-8.5061	0.79269	0.99826	7	-8.5552	0.66648	0.99965
"166"	"NF-kappa B signaling pathway"	20	0.23944	0.64222	1	-0.23944	0.35778	0.60962	-20.199	0.99046	0.99992	7	-8.9187	0.78456	0.99826	13	-18.509	0.99142	0.99965
"167"	"NOD-like receptor signaling pathway"	50	0.34722	0.75987	1	-0.34722	0.24013	0.48502	-20.931	0.86525	0.99992	21	-10.221	0.56481	0.99826	29	-18.786	0.89524	0.99965
"168"	"Natural killer cell mediated cytotoxicity"	27	-2.2246	0.99498	1	2.2246	0.0050168	0.044305	-11.157	0.4031	0.91365	8	-10.971	0.90396	0.99826	19	-6.1807	0.099649	0.78638
"169"	"Necroptosis"	58	0.34675	0.77334	1	-0.34675	0.22666	0.47027	-16.432	0.41475	0.91644	25	-5.652	0.13656	0.74242	33	-16.865	0.70581	0.99965
"170"	"Neomycin, kanamycin and gentamicin biosynthesis"	2	0.94159	0.26614	1	-0.94159	0.73386	0.92874	-0.3505	0.23623	0.73863	2	-0.3505	0.26776	0.8866	0			
"171"	"Neuroactive ligand-receptor interaction"	9	0.49881	0.47039	1	-0.49881	0.52961	0.74782	-7.793	0.59854	0.99992	7	-5.0431	0.43601	0.96519	2	-7.0966	0.82157	0.99965
"172"	"Neurotrophin signaling pathway"	48	-2.8903	0.99981	1	2.8903	0.00019319	0.0042087	-18.188	0.73067	0.99992	15	-9.2915	0.63224	0.99826	33	-15.671	0.59158	0.98257
"173"	"Nicotinate and nicotinamide metabolism"	18	1.0691	0.38295	1	-1.0691	0.61705	0.82184	-12.819	0.75635	0.99992	12	-11.943	0.86453	0.99826	6	-5.3123	0.40993	0.934
"174"	"Nitrogen metabolism"	7	0.94184	0.33043	1	-0.94184	0.66957	0.86901	-0.29652	0.080009	0.46432	4	0.67225	0.12589	0.72319	3	-1.2292	0.20781	0.82756
"175"	"Non-alcoholic fatty liver disease (NAFLD)"	96	17.856	0	0	-17.856	1	1	2.1304	4.1768e-09	1.8199e-07	77	12.136	6.6724e-14	3.314e-12	19	-19.643	0.98477	0.99965
"176"	"Non-homologous end-joining"	5	-0.40669	0.75235	1	0.40669	0.24765	0.49047	-5.3254	0.49547	0.98009	2	-2.2655	0.44032	0.96519	3	-5.0252	0.56088	0.97431
"177"	"Non-small cell lung cancer"	23	-0.71386	0.88971	1	0.71386	0.11029	0.31437	-14.117	0.76883	0.99992	11	-10.936	0.83269	0.99826	12	-9.0741	0.53061	0.96187
"178"	"Notch signaling pathway"	6	0.38078	0.50064	1	-0.38078	0.49936	0.72531	-16.601	0.99586	0.99992	3	-9.2586	0.90672	0.99826	3	-14.219	0.99372	0.99965
"179"	"Nucleotide excision repair"	11	-2.0693	0.98885	1	2.0693	0.011151	0.079095	-9.354	0.65392	0.99992	1	-8.2095	0.92946	0.99826	10	-7.2145	0.43016	0.94189
"180"	"Olfactory transduction"	11	-2.9324	0.99884	1	2.9324	0.0011624	0.016882	-8.2767	0.55546	0.99992	0				11	-8.2767	0.50424	0.94831
"181"	"One carbon pool by folate"	11	-0.47606	0.81115	1	0.47606	0.18885	0.42666	-6.9142	0.42667	0.91644	4	-0.23294	0.176	0.78225	7	-8.4913	0.66068	0.99965
"182"	"Oocyte meiosis"	41	-5.8199	1	1	5.8199	4.3668e-09	6.6594e-07	-7.2735	0.03676	0.30302	4	-4.5889	0.54199	0.99826	37	-6.1477	0.0099589	0.33513
"183"	"Osteoclast differentiation"	32	-2.1138	0.99416	1	2.1138	0.0058397	0.048138	-19.627	0.95502	0.99992	8	-9.5892	0.83285	0.99826	24	-17.127	0.87351	0.99965
"184"	"Other glycan degradation"	6	0.77499	0.36699	1	-0.77499	0.63301	0.83579	-6.8406	0.60281	0.99992	5	-7.5912	0.73897	0.99826	1	0.21854	0.25103	0.85714
"185"	"Other types of O-glycan biosynthesis"	4	0.037201	0.5982	1	-0.037201	0.4018	0.64841	-5.1286	0.54828	0.99992	2	-5.9704	0.77577	0.99826	2	-1.2826	0.278	0.85849
"186"	"Ovarian steroidogenesis"	9	0.3388	0.52309	1	-0.3388	0.47691	0.70955	-10.886	0.84407	0.99992	2	-4.1562	0.62297	0.99826	7	-10.122	0.79387	0.99965
"187"	"Oxidative phosphorylation"	93	23.064	0	0	-23.064	1	1	17.119	0	0	89	18.453	0	0	4	-4.499	0.45224	0.94677
"188"	"Oxytocin signaling pathway"	63	-4.6244	1	1	4.6244	9.0453e-08	6.897e-06	-11.914	0.05389	0.39807	18	-10.114	0.60802	0.99826	45	-7.7008	0.0076793	0.33513
"189"	"PI3K-Akt signaling pathway"	101	0.53359	0.81567	1	-0.53359	0.18433	0.41956	-30.863	0.97304	0.99992	49	-17.789	0.76611	0.99826	52	-25.745	0.96917	0.99965
"190"	"PPAR signaling pathway"	35	6.3097	4.5528e-06	7.3085e-05	-6.3097	1	1	-5.7141	0.023149	0.24346	30	-1.6009	0.0069813	0.12238	5	-11.197	0.919	0.99965
"191"	"Pancreatic cancer"	31	-0.056305	0.80714	1	0.056305	0.19286	0.42936	-19.217	0.93761	0.99992	13	-9.263	0.65249	0.99826	18	-17.348	0.95934	0.99965
"192"	"Pancreatic secretion"	23	-0.96219	0.9239	1	0.96219	0.076103	0.24693	-11.604	0.54147	0.99992	8	-6.897	0.61987	0.99826	15	-9.3316	0.46637	0.94677
"193"	"Pantothenate and CoA biosynthesis"	8	1.0437	0.32072	1	-1.0437	0.67928	0.87789	-8.5296	0.67772	0.99992	7	-9.208	0.80469	0.99826	1	0.23667	0.24958	0.85714
"194"	"Parathyroid hormone synthesis, secretion and action"	23	-0.53239	0.85856	1	0.53239	0.14144	0.36785	-14.606	0.80448	0.99992	6	-6.394	0.61687	0.99826	17	-13.191	0.74688	0.99965
"195"	"Parkinson disease"	98	22.024	0	0	-22.024	1	1	15.43	0	0	85	20.351	0	0	13	-9.6745	0.54301	0.96187
"196"	"Pathogenic Escherichia coli infection"	33	-0.018437	0.7966	1	0.018437	0.2034	0.44631	-11.309	0.30669	0.82714	16	-8.8519	0.53007	0.99826	17	-7.1692	0.20531	0.82756
"197"	"Pathways in cancer"	140	0.7204	0.85475	1	-0.7204	0.14525	0.37227	-33.427	0.93289	0.99992	64	-14.907	0.30517	0.90941	76	-31.689	0.99121	0.99965
"198"	"Pentose and glucuronate interconversions"	7	1.7198	0.13766	0.80744	-1.7198	0.86234	1	0.09952	0.066488	0.43011	5	0.79383	0.091606	0.65527	2	-1.069	0.2597	0.85849
"199"	"Pentose phosphate pathway"	22	-2.2549	0.99492	1	2.2549	0.0050841	0.044305	-6.6542	0.14844	0.64677	11	-9.9778	0.76903	0.99826	11	0.56726	0.013722	0.39657
"200"	"Peroxisome"	42	6.4315	2.4846e-06	4.229e-05	-6.4315	1	1	-12.368	0.25997	0.74513	34	-8.879	0.1962	0.83969	8	-10.035	0.76113	0.99965
"201"	"Pertussis"	28	0.10876	0.76183	1	-0.10876	0.23817	0.48502	-11.766	0.4682	0.95201	13	-5.1799	0.28054	0.88798	15	-11.253	0.64594	0.99965
"202"	"Phagosome"	59	0.68115	0.69069	1	-0.68115	0.30931	0.55248	-14.118	0.19155	0.70254	35	-11.938	0.45413	0.96665	24	-7.7198	0.12565	0.80097
"203"	"Phenylalanine metabolism"	6	3.6579	0.0022783	0.023962	-3.6579	0.99772	1	-1.0425	0.12442	0.63245	5	2.5294	0.041024	0.45242	1	-8.2095	0.92488	0.99965
"204"	"Phenylalanine, tyrosine and tryptophan biosynthesis"	2	4.3188	0.00029601	0.0037617	-4.3188	0.9997	1	4.015	0.036181	0.30302	2	4.015	0.045545	0.45242	0			
"205"	"Phosphatidylinositol signaling system"	28	-1.1817	0.96456	1	1.1817	0.035436	0.16132	-16.939	0.88143	0.99992	12	-14.626	0.95919	0.99826	16	-9.7425	0.46059	0.94677
"206"	"Phospholipase D signaling pathway"	40	-0.90841	0.95526	1	0.90841	0.044739	0.18286	-13.931	0.42484	0.91644	18	-11.64	0.73992	0.99826	22	-8.2562	0.18086	0.82756
"207"	"Phosphonate and phosphinate metabolism"	2	2.0887	0.057137	0.44684	-2.0887	0.94286	1	1.4947	0.12014	0.62105	2	1.4947	0.14188	0.75501	0			
"208"	"Phototransduction"	2	-0.31453	0.66309	1	0.31453	0.33691	0.59397	-6.0898	0.75779	0.99992	0				2	-6.0898	0.74533	0.99965
"209"	"Platelet activation"	53	0.44764	0.74873	1	-0.44764	0.25127	0.49202	-17.345	0.54502	0.99992	26	-10.853	0.49909	0.97958	27	-13.651	0.53819	0.96187
"210"	"Porphyrin and chlorophyll metabolism"	18	3.55	0.0087679	0.081036	-3.55	0.99123	1	-2.1493	0.02871	0.28441	14	0.020637	0.032757	0.40673	4	-4.598	0.46235	0.94677
"211"	"Primary bile acid biosynthesis"	6	1.9217	0.091258	0.57987	-1.9217	0.90874	1	-2.9964	0.24928	0.73863	6	-2.9964	0.29567	0.89909	0			
"212"	"Primary immunodeficiency"	3	0.98476	0.29389	1	-0.98476	0.70611	0.90489	-8.6986	0.88242	0.99992	2	-4.8485	0.68545	0.99826	1	-8.2095	0.92488	0.99965
"213"	"Prion diseases"	21	0.71522	0.50127	1	-0.71522	0.49873	0.72531	-15.29	0.87237	0.99992	13	-13.758	0.92833	0.99826	8	-7.2347	0.50533	0.94831
"214"	"Progesterone-mediated oocyte maturation"	25	-0.23	0.82021	1	0.23	0.17979	0.41231	-14.973	0.79442	0.99992	8	-3.0346	0.26037	0.88478	17	-16.076	0.9158	0.99965
"215"	"Prolactin signaling pathway"	24	-1.2135	0.95136	1	1.2135	0.048643	0.1931	-14.017	0.75372	0.99992	7	-4.8018	0.41287	0.96519	17	-13.574	0.77617	0.99965
"216"	"Propanoate metabolism"	29	11.027	0	0	-11.027	1	1	4.5257	1.8663e-05	0.00049465	26	6.1645	1.8608e-05	0.00050411	3	-4.0769	0.46477	0.94677
"217"	"Prostate cancer"	30	-0.20612	0.83139	1	0.20612	0.16861	0.39866	-19.513	0.9553	0.99992	12	-9.4582	0.69412	0.99826	18	-17.469	0.96197	0.99965
"218"	"Proteasome"	39	-6.4229	1	1	6.4229	1.8645e-11	5.6868e-09	1.5747	4.4764e-05	0.0010502	4	0.5217	0.13345	0.74242	35	1.4859	9.473e-06	0.0027377
"219"	"Protein digestion and absorption"	26	0.42929	0.62676	1	-0.42929	0.37324	0.61869	-12.352	0.55851	0.99992	13	-4.3519	0.21811	0.83969	13	-13.117	0.84	0.99965
"220"	"Protein export"	14	-0.10288	0.74047	1	0.10288	0.25953	0.501	-5.5089	0.2208	0.72413	5	-6.9652	0.689	0.99826	9	-1.6792	0.076136	0.73345
"221"	"Protein processing in endoplasmic reticulum"	97	-2.6138	0.99987	1	2.6138	0.00012716	0.0032084	-20.034	0.24664	0.73863	40	-16.843	0.80856	0.99826	57	-12.026	0.030117	0.5887
"222"	"Proteoglycans in cancer"	83	-1.7441	0.99609	1	1.7441	0.003906	0.03843	-18.392	0.26141	0.74513	38	-17.69	0.86921	0.99826	45	-8.7226	0.01514	0.39776
"223"	"Proximal tubule bicarbonate reclamation"	10	2.062	0.089881	0.57987	-2.062	0.91012	1	-1.5813	0.080686	0.46432	6	-0.94809	0.14922	0.7667	4	-1.3391	0.17542	0.82271
"224"	"Purine metabolism"	56	-0.65174	0.9432	1	0.65174	0.056799	0.20144	-12.522	0.13062	0.64677	30	-14.097	0.70514	0.99826	26	-3.235	0.0063364	0.33513
"225"	"Pyrimidine metabolism"	28	0.99181	0.48546	1	-0.99181	0.51454	0.73334	-18.943	0.95264	0.99992	19	-18.478	0.98973	0.99826	9	-6.5653	0.40757	0.934
"226"	"Pyruvate metabolism"	34	6.1894	2.4958e-06	4.229e-05	-6.1894	1	1	0.2563	0.00060848	0.012373	23	1.4604	0.0030109	0.059816	11	-1.6612	0.049796	0.61297
"227"	"RIG-I-like receptor signaling pathway"	21	0.55399	0.55754	1	-0.55399	0.44246	0.68853	-19.272	0.98291	0.99992	9	-10.18	0.81769	0.99826	12	-16.678	0.97799	0.99965
"228"	"RNA degradation"	36	0.19165	0.74262	1	-0.19165	0.25738	0.5	-18.236	0.85922	0.99992	19	-15.938	0.9548	0.99826	17	-9.688	0.42051	0.94189
"229"	"RNA polymerase"	9	-0.91349	0.86269	1	0.91349	0.13731	0.36417	-21.057	0.99978	0.99992	3	-14.219	0.99341	0.99826	6	-15.735	0.99287	0.99965
"230"	"RNA transport"	92	-4.6706	1	1	4.6706	2.9365e-08	2.9855e-06	-20.816	0.36223	0.89745	20	-15.606	0.93352	0.99826	72	-15.306	0.053284	0.61297
"231"	"Rap1 signaling pathway"	52	0.22517	0.76642	1	-0.22517	0.23358	0.48136	-15.826	0.4044	0.91365	23	-6.6299	0.21516	0.83969	29	-15.288	0.64583	0.99965
"232"	"Ras signaling pathway"	59	0.089357	0.84198	1	-0.089357	0.15802	0.38558	-25.772	0.97865	0.99992	22	-7.2218	0.26189	0.88478	37	-26.975	0.99747	0.99965
"233"	"Regulation of actin cytoskeleton"	97	-0.8147	0.98196	1	0.8147	0.018037	0.10471	-17.87	0.10979	0.59796	55	-17.187	0.64499	0.99826	42	-7.4898	0.010437	0.33513
"234"	"Regulation of lipolysis in adipocytes"	16	1.4674	0.24357	1	-1.4674	0.75643	0.94296	-13.839	0.8612	0.99992	7	-1.7487	0.16663	0.78225	9	-16.91	0.98933	0.99965
"235"	"Relaxin signaling pathway"	41	0.033877	0.79057	1	-0.033877	0.20943	0.44984	-17.894	0.76753	0.99992	15	-5.1547	0.24771	0.88478	26	-18.555	0.90153	0.99965
"236"	"Renal cell carcinoma"	30	-0.6247	0.90825	1	0.6247	0.091753	0.28222	-9.3965	0.22669	0.73554	11	-2.991	0.17469	0.78225	19	-9.5315	0.33526	0.87289
"237"	"Renin secretion"	19	-1.275	0.95894	1	1.275	0.041059	0.17393	-6.3593	0.18605	0.69718	9	-7.9227	0.64362	0.99826	10	-1.2496	0.051497	0.61297
"238"	"Renin-angiotensin system"	11	-0.10352	0.71024	1	0.10352	0.28976	0.53672	-3.545	0.16185	0.64953	5	-3.7743	0.39856	0.96519	6	-1.3545	0.10663	0.79773
"239"	"Retinol metabolism"	9	2.0339	0.089715	0.57987	-2.0339	0.91028	1	-5.3771	0.36486	0.89745	9	-5.3771	0.40551	0.96519	0			
"240"	"Retrograde endocannabinoid signaling"	61	13.872	0	0	-13.872	1	1	5.5004	2.2692e-09	1.1535e-07	47	12.282	6.6716e-11	2.8402e-09	14	-11.021	0.62752	0.99965
"241"	"Rheumatoid arthritis"	16	0.99264	0.39254	1	-0.99264	0.60746	0.8198	-10.757	0.62832	0.99992	12	-9.8862	0.72898	0.99826	4	-4.3911	0.44127	0.94677
"242"	"Riboflavin metabolism"	5	0.19734	0.56969	1	-0.19734	0.43031	0.67702	-3.9548	0.36227	0.89745	3	-4.9266	0.62161	0.99826	2	-0.21919	0.19352	0.82756
"243"	"Ribosome"	111	1.7719	0.45333	1	-1.7719	0.54667	0.75106	-11.877	0.00099145	0.017819	51	-8.4084	0.055825	0.50233	60	-8.4029	0.0022268	0.21452
"244"	"Ribosome biogenesis in eukaryotes"	22	-1.249	0.95504	1	1.249	0.044965	0.18286	-15.306	0.87233	0.99992	6	-7.3314	0.70105	0.99826	16	-13.458	0.80525	0.99965
"245"	"SNARE interactions in vesicular transport"	18	-1.0955	0.93509	1	1.0955	0.064907	0.22243	-15.837	0.92344	0.99992	9	-14.857	0.97843	0.99826	9	-7.5397	0.50202	0.94831
"246"	"Salivary secretion"	22	-0.45337	0.84236	1	0.45337	0.15764	0.38558	-12.243	0.6426	0.99992	9	-9.4206	0.76592	0.99826	13	-8.0878	0.38186	0.91964
"247"	"Salmonella infection"	45	0.028505	0.80526	1	-0.028505	0.19474	0.4304	-10.867	0.1352	0.64677	21	-3.6295	0.074219	0.59776	24	-11.485	0.40891	0.934
"248"	"Selenocompound metabolism"	9	1.5271	0.1778	0.96837	-1.5271	0.8222	1	0.31087	0.040363	0.32397	6	1.1263	0.060685	0.50233	3	-1.0544	0.19529	0.82756
"249"	"Serotonergic synapse"	26	0.75277	0.51686	1	-0.75277	0.48314	0.71532	-10.96	0.41626	0.91644	11	-3.8468	0.23237	0.86559	15	-11.135	0.63537	0.99965
"250"	"Shigellosis"	39	0.633	0.65013	1	-0.633	0.34987	0.60077	-14.567	0.48709	0.97739	21	-9.0256	0.44888	0.96519	18	-11.694	0.61788	0.99965
"251"	"Signaling pathways regulating pluripotency of stem cells"	19	-1.8038	0.98606	1	1.8038	0.013945	0.085503	-10.659	0.55346	0.99992	5	-7.4812	0.7305	0.99826	14	-7.9464	0.32449	0.85849
"252"	"Small cell lung cancer"	34	2.0195	0.17343	0.96837	-2.0195	0.82657	1	-24.011	0.99501	0.99992	17	-10.378	0.6718	0.99826	17	-23.578	0.99938	0.99965
"253"	"Sphingolipid metabolism"	7	0.7686	0.38457	1	-0.7686	0.61543	0.82184	-14.283	0.97917	0.99992	6	-15.613	0.99478	0.99826	1	0.45576	0.2325	0.85052
"254"	"Sphingolipid signaling pathway"	45	-0.065699	0.82699	1	0.065699	0.17301	0.40282	-18.146	0.73237	0.99992	17	-7.4764	0.39849	0.96519	28	-17.179	0.81416	0.99965
"255"	"Spliceosome"	94	-3.3481	0.99999	1	3.3481	1.2066e-05	0.000736	-31.748	0.99107	0.99992	25	-23.007	0.99826	0.99826	69	-23.207	0.71035	0.99965
"256"	"Staphylococcus aureus infection"	15	0.34732	0.58873	1	-0.34732	0.41127	0.65674	-11.721	0.73437	0.99992	11	-11.804	0.87953	0.99826	4	-3.1219	0.31765	0.85849
"257"	"Starch and sucrose metabolism"	19	-1.4309	0.96955	1	1.4309	0.03045	0.15375	-5.9259	0.15961	0.64909	11	-8.7349	0.66942	0.99826	8	1.1102	0.019567	0.43508
"258"	"Steroid biosynthesis"	6	-0.21899	0.69884	1	0.21899	0.30116	0.55202	-9.6591	0.82841	0.99992	5	-11.173	0.93086	0.99826	1	1.3239	0.17157	0.82271
"259"	"Steroid hormone biosynthesis"	6	1.3	0.21344	1	-1.3	0.78656	0.96346	-2.0806	0.18404	0.69718	3	1.8837	0.1003	0.65833	3	-4.8261	0.5408	0.96187
"260"	"Sulfur metabolism"	6	3.4473	0.0039725	0.039084	-3.4473	0.99603	1	1.7186	0.033891	0.29533	6	1.7186	0.045088	0.45242	0			
"261"	"Sulfur relay system"	6	2.4594	0.036028	0.29699	-2.4594	0.96397	1	-2.4893	0.21174	0.71482	6	-2.4893	0.25418	0.88478	0			
"262"	"Synaptic vesicle cycle"	24	0.75348	0.49972	1	-0.75348	0.50028	0.72531	-9.3633	0.32026	0.83486	15	-7.1471	0.42439	0.96519	9	-6.0633	0.3606	0.89839
"263"	"Synthesis and degradation of ketone bodies"	8	4.3299	0.0005976	0.0067507	-4.3299	0.9994	1	-2.185	0.14222	0.64677	8	-2.185	0.1975	0.83969	0			
"264"	"Systemic lupus erythematosus"	22	-0.23427	0.79211	1	0.23427	0.20789	0.44984	-11.889	0.6088	0.99992	16	-13.786	0.89076	0.99826	6	-0.25305	0.063293	0.63733
"265"	"T cell receptor signaling pathway"	36	-2.2414	0.99681	1	2.2414	0.0031884	0.034731	-15.726	0.67742	0.99992	10	-8.5142	0.66779	0.99826	26	-13.224	0.48957	0.94831
"266"	"TGF-beta signaling pathway"	15	-1.6457	0.97091	1	1.6457	0.029094	0.1504	-10.567	0.63449	0.99992	5	-8.4066	0.79726	0.99826	10	-6.9978	0.40951	0.934
"267"	"TNF signaling pathway"	26	-0.64091	0.89489	1	0.64091	0.10511	0.30245	-20.034	0.98325	0.99992	10	-9.5314	0.75314	0.99826	16	-18.004	0.97904	0.99965
"268"	"Taste transduction"	2	-0.14236	0.60935	1	0.14236	0.39065	0.64059	-6.5095	0.78898	0.99992	0				2	-6.5095	0.77901	0.99965
"269"	"Taurine and hypotaurine metabolism"	2	1.6277	0.11594	0.70723	-1.6277	0.88406	1	-4.3719	0.60829	0.99992	1	2.0268	0.15842	0.78225	1	-8.2095	0.92488	0.99965
"270"	"Terpenoid backbone biosynthesis"	15	1.2148	0.30762	1	-1.2148	0.69238	0.89104	-10.004	0.58156	0.99992	10	-9.3586	0.73952	0.99826	5	-4.0922	0.35071	0.89695
"271"	"Th1 and Th2 cell differentiation"	22	-1.8255	0.98598	1	1.8255	0.014017	0.085503	-12.432	0.66023	0.99992	8	-10.392	0.87746	0.99826	14	-7.7284	0.30485	0.85849
"272"	"Th17 cell differentiation"	28	-1.8089	0.99031	1	1.8089	0.0096937	0.070395	-12.107	0.50129	0.98009	10	-8.9104	0.70244	0.99826	18	-8.4582	0.29949	0.85849
"273"	"Thermogenesis"	132	20.207	0	0	-20.207	1	1	4.214	1.7653e-14	1.346e-12	108	11.469	0	0	24	-14.446	0.68811	0.99965
"274"	"Thiamine metabolism"	7	1.3062	0.2284	1	-1.3062	0.7716	0.95665	-2.3923	0.18693	0.69718	5	-2.8473	0.3174	0.9174	2	0.026387	0.1765	0.82271
"275"	"Thyroid cancer"	11	-0.75179	0.8697	1	0.75179	0.1303	0.35671	-4.7623	0.24286	0.73863	4	-3.9567	0.48208	0.97958	7	-2.9788	0.16925	0.82271
"276"	"Thyroid hormone signaling pathway"	42	-1.0515	0.96014	1	1.0515	0.039859	0.17147	-15.892	0.58911	0.99992	16	-9.9245	0.62801	0.99826	26	-12.413	0.41044	0.934
"277"	"Thyroid hormone synthesis"	21	0.75309	0.488	1	-0.75309	0.512	0.73334	-6.8186	0.17154	0.67077	12	-3.2304	0.16368	0.78225	9	-6.6855	0.41904	0.94189
"278"	"Tight junction"	80	-1.4821	0.99347	1	1.4821	0.0065307	0.052417	-23.916	0.78358	0.99992	41	-19.42	0.91708	0.99826	39	-14.341	0.35712	0.89746
"279"	"Toll-like receptor signaling pathway"	29	-0.52956	0.86784	1	0.52956	0.13216	0.35671	-18.981	0.94542	0.99992	10	-6.6457	0.48944	0.97958	19	-18.629	0.97157	0.99965
"280"	"Toxoplasmosis"	41	1.4127	0.36077	1	-1.4127	0.63923	0.84037	-14.144	0.43675	0.92506	22	-5.6952	0.1564	0.78225	19	-14.648	0.81192	0.99965
"281"	"Transcriptional misregulation in cancer"	23	0.61415	0.54742	1	-0.61415	0.45258	0.69715	-26.26	0.99992	0.99992	11	-14.918	0.97241	0.99826	12	-22.072	0.99965	0.99965
"282"	"Tryptophan metabolism"	21	6.2333	6.4417e-07	1.228e-05	-6.2333	1	1	-0.71988	0.0071488	0.10383	19	-0.87356	0.022711	0.31553	2	0.35981	0.15496	0.80097
"283"	"Tuberculosis"	54	-0.62122	0.94533	1	0.62122	0.054668	0.1985	-16.397	0.43675	0.92506	22	-8.7738	0.39762	0.96519	32	-14.025	0.45924	0.94677
"284"	"Type I diabetes mellitus"	5	1.3117	0.22406	1	-1.3117	0.77594	0.95814	-6.8378	0.64244	0.99992	4	-7.3662	0.77818	0.99826	1	-0.55719	0.31666	0.85849
"285"	"Type II diabetes mellitus"	18	0.85004	0.45449	1	-0.85004	0.54551	0.75106	-13.628	0.81363	0.99992	9	-5.2649	0.39517	0.96519	9	-14.008	0.94415	0.99965
"286"	"Tyrosine metabolism"	13	3.7856	0.0033483	0.034041	-3.7856	0.99665	1	-0.37731	0.022626	0.24346	11	1.9904	0.01669	0.24868	2	-5.6299	0.70554	0.99965
"287"	"Ubiquinone and other terpenoid-quinone biosynthesis"	6	4.3289	0.00031545	0.0038485	-4.3289	0.99968	1	-2.7716	0.23222	0.73778	5	0.63524	0.097893	0.65833	1	-8.2095	0.92488	0.99965
"288"	"Ubiquitin mediated proteolysis"	51	-2.4317	0.99907	1	2.4317	0.00092889	0.014166	-21.962	0.91195	0.99992	11	-12.396	0.90562	0.99826	40	-18.298	0.69019	0.99965
"289"	"VEGF signaling pathway"	28	-2.2281	0.99646	1	2.2281	0.0035362	0.037191	-11.098	0.40404	0.91365	9	-8.4128	0.68619	0.99826	19	-7.6818	0.18429	0.82756
"290"	"Valine, leucine and isoleucine degradation"	41	13.566	0	0	-13.566	1	1	7.3112	7.5765e-08	2.8885e-06	38	8.8435	9.8407e-08	3.2584e-06	3	-4.446	0.50224	0.94831
"291"	"Vascular smooth muscle contraction"	40	-0.83419	0.94872	1	0.83419	0.051284	0.1931	-11.327	0.20343	0.70507	17	-8.5682	0.50278	0.97958	23	-7.5707	0.11236	0.79773
"292"	"Vasopressin-regulated water reabsorption"	22	-0.79344	0.90316	1	0.79344	0.096837	0.28699	-6.0102	0.11401	0.61003	10	-6.1783	0.44369	0.96519	12	-2.4978	0.054963	0.61297
"293"	"Vibrio cholerae infection"	21	0.43137	0.59963	1	-0.43137	0.40037	0.64841	-7.544	0.2208	0.72413	11	-5.0493	0.32875	0.92212	10	-5.6366	0.28749	0.85849
"294"	"Viral carcinogenesis"	66	-2.2776	0.9993	1	2.2776	0.00069775	0.011201	-18.983	0.52601	0.99992	21	-8.913	0.43803	0.96519	45	-16.9	0.45768	0.94677
"295"	"Viral myocarditis"	25	0.013094	0.76115	1	-0.013094	0.23885	0.48502	-7.6658	0.1563	0.64909	11	-6.3796	0.45021	0.96519	14	-4.589	0.095556	0.78638
"296"	"Vitamin B6 metabolism"	3	-0.27456	0.69413	1	0.27456	0.30587	0.55202	-0.35894	0.18744	0.69718	2	-0.98534	0.32133	0.9174	1	0.77177	0.20904	0.82756
"297"	"Vitamin digestion and absorption"	5	0.12294	0.59404	1	-0.12294	0.40596	0.65167	-4.1772	0.38321	0.9053	2	-0.21486	0.25693	0.88478	3	-5.2173	0.58009	0.97431
"298"	"Wnt signaling pathway"	37	-3.5792	0.99995	1	3.5792	4.8487e-05	0.0018486	-12.832	0.38587	0.9053	9	-5.9843	0.46245	0.96757	28	-11.358	0.27094	0.85849
"299"	"alpha-Linolenic acid metabolism"	4	0.79905	0.3465	1	-0.79905	0.6535	0.85544	-7.4804	0.7638	0.99992	2	-4.5437	0.65846	0.99826	2	-6.0351	0.74075	0.99965
"300"	"beta-Alanine metabolism"	18	4.2369	0.0015864	0.01728	-4.2369	0.99841	1	-1.2301	0.016849	0.20556	14	-1.9036	0.08389	0.641	4	0.95201	0.063953	0.63733
"301"	"cAMP signaling pathway"	56	-2.1763	0.99787	1	2.1763	0.0021293	0.024979	-14.822	0.28555	0.80643	22	-7.5558	0.28904	0.88798	34	-12.944	0.30712	0.85849
"302"	"cGMP-PKG signaling pathway"	56	-0.097614	0.8683	1	0.097614	0.1317	0.35671	-8.6601	0.019743	0.22697	28	-4.7166	0.059317	0.50233	28	-7.5307	0.054979	0.61297
"303"	"mRNA surveillance pathway"	43	-2.315	0.99791	1	2.315	0.0020877	0.024979	-19.118	0.83809	0.99992	11	-6.0055	0.41503	0.96519	32	-18.64	0.85579	0.99965
"304"	"mTOR signaling pathway"	59	-1.0263	0.97466	1	1.0263	0.025337	0.13558	-19.533	0.68253	0.99992	25	-10.398	0.5011	0.97958	34	-16.815	0.67303	0.99965
"305"	"p53 signaling pathway"	11	0.53071	0.49823	1	-0.53071	0.50177	0.72531	-13.133	0.90241	0.99992	4	-8.1624	0.83033	0.99826	7	-10.292	0.80576	0.99965
